Brian J Druker (Brian Druker, John C Byrd)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 43

Top Venues

Leukemia

Blood advances

Clinical and translational medicine

Blood

Oregon Health & Science University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Oregon Health & Science University

United States

Associate Dean for Oncology :: School of Medicine

Publications

Sheng F Cai, Ying Huang, Jennie R Lance, Hsiao-Yin Charlene Charlene Mao, Andrew Dunbar, Samantha McNulty, Todd E Druley, Yan Li, Maria R Baer, Wendy Stock, Tibor Kovacsovics, William Blum, Gary J Schiller, Rebecca L Olin, James M Foran, Mark R Litzow, Tara L Lin, Prapti Arvind Patel, Matthew C Foster, Michael Boyiadzis, Robert H Collins, Jordan Chervin, Abigail B Shoben, Jo-Anne Vergilio, Nyla A Heerema, Leonard Rosenberg, Timothy L Chen, Ashley O Yocum, Franchesca Druggan, Sonja Marcus, Mona Stefanos, Brian J Druker, Alice S Mims, Uma Borate, Amy Burd, John C Byrd, Ross L Levine, Eytan M Stein
A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2-mutant AML. Blood advances (2023)
Olivia M Lucero, Ji-Ann Lee, Jenna Bowman, Kara Johnson, Gopal Sapparapu, John K Thomas, Guang Fan, Bill H Chang, Karina Thiel-Klare, Christopher A Eide, Craig Okada, Mike Palazzolo, Evan F Lind, Yoko Kosaka, Brian J Druker, Nicholas Lydon, Peter M Bowers
Patient Specific Targeting of the T-cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Sunil Kumar Joshi, Tamilla Nechiporuk, Ariane Huang, Charles A Dibb, Akosha Taylor, Daniel Bottomly, Shannon K McWeeney, Jessica Minnier, Curtis A Lachowiez, Jennifer N Saultz, Ronan T Swords, Anupriya Agarwal, Bill H Chang, Brian J Druker, Jeffrey W Tyner
Clinical Correlates of Venetoclax-based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy. Blood cancer discovery (2023)
William M Yashar, Brittany M Curtiss, Daniel J Coleman, Jake VanCampen, Garth L Kong, Jommel Macaraeg, Joseph Estabrook, Emek Demir, Nicola Long, Daniel Bottomly, Shannon K McWeeney, Jeffrey W Tyner, Brian J Druker, Julia E Maxson, Theodore P Braun
Disruption of the MYC Super-Enhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia. Molecular cancer research : MCR (2023)
Uma Borate, Fei Yang, Richard D Press, Amy S Ruppert, Daniel Jones, Sean Caruthers, Weiqiang Zhao, Jo-Anne Vergilio, Dean Pavlick, Luke Juckett, Brianna A Norris, Taylor I Bucy, Amy Burd, Eytan M Stein, Prapti Arvind Patel, Maria R Baer, Wendy Stock, Gary J Schiller, William Blum, Tibor J Kovacsovics, Mark R Litzow, James M Foran, Nyla A Heerema, Leonard Rosenberg, Sonja Marcus, Ashley O Yocum, Mona Stefanos, Brian J Druker, Alice S Mims
AML Samples Show High Concordance in Detection of Mutations by NGS at Local Institutions versus Central Laboratories. Blood advances (2023)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Mara W Rosenberg, Samantha L Savage, Christopher A Eide, Anna Reister Schultz, Rachel J Cook, Richard D Press, Carole Rempfer, Garrett Eickelberg, Beth Wilmot, Shannon K McWeeney, Jeffrey W Tyner, Brian J Druker, Cristina E Tognon
Comprehensive molecular characterization of a rare case of Philadelphia chromosome-positive acute myeloid leukemia. Cold Spring Harbor molecular case studies 8 (6) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Antoine N Saliba, Scott H Kaufmann, Eytan M Stein, Prapti Arvind Patel, Maria R Baer, Wendy Stock, Michael W Deininger, William Blum, Gary J Schiller, Rebecca L Olin, Mark R Litzow, Tara L Lin, Brian John Ball, Michael Boyiadzis, Jennifer Dunlap, Olatoyosi Odenike, Martha L Arellano, Alison R Walker, Vu H Duong, Tibor J Kovacsovics, Robert H Collins, Abigail B Shoben, Nyla A Heerema, Matthew C Foster, Kevin L Peterson, Paula A Schneider, Molly Martycz, Theophilus Gana, Leonard Rosenberg, Sonja Marcus, Ashley O Yocum, Timothy L Chen, Mona Stefanos, Alice S Mims, Uma Borate, Amy Burd, Brian J Druker, Ross L Levine, John C Byrd, James M Foran
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates. Blood advances (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Sarah A Carratt, Garth L Kong, Brittany M Curtiss, Zachary Schonrock, Lauren Maloney, Breanna N Maniaci, Hunter Z Blaylock, Adrian Baris, Brian J Druker, Theodore P Braun, Julia E Maxson
Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R-driven myeloproliferative neoplasms. Blood 140 (6) (2022)
Theodore P Braun, Mariam Okhovat, Cody Coblentz, Sarah A Carratt, Amy Foley, Zachary Schonrock, Brittany M Curtiss, Kimberly Nevonen, Brett A Davis, Brianna Garcia, Dorian LaTocha, Benjamin R Weeder, Michal R Grzadkowski, Joey C Estabrook, Hannah G Manning, Kevin Watanabe-Smith, Sophia Jeng, Jenny L Smith, Amanda R Leonti, Rhonda E Ries, Shannon K McWeeney, Cristina Di Genua, Roy Drissen, Claus Nerlov, Soheil Meshinchi, Lucia Carbone, Brian J Druker, Julia E Maxson
Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia. Nature communications 13 (1) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Brittany M Curtiss, Jake VanCampen, Jommel Macaraeg, Garth L Kong, Akram Taherinasab, Mitsuhiro Tsuchiya, William M Yashar, Yiu H Tsang, Wesley Horton, Daniel J Coleman, Joseph Estabrook, Theresa A Lusardi, Gordon B Mills, Brian J Druker, Julia E Maxson, Theodore P Braun
PU.1 and MYC transcriptional network defines synergistic drug responses to KIT and LSD1 inhibition in acute myeloid leukemia. Leukemia 36 (7) (2022)
Curtis A Lachowiez, Nicola Long, Jennifer N Saultz, Arpita Gandhi, Laura F Newell, Brandon Hayes-Lattin, Richard T Maziarz, Jessica T Leonard, Daniel Bottomly, Shannon K McWeeney, Jennifer Dunlap, Richard D Press, Gabrielle Meyers, Ronan Swords, Rachel Cook, Jeffrey W Tyner, Brian J Druker, Jennifer Dunlap
Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia. Blood advances (2022)
Stephen E Kurtz, Christopher A Eide, Andy Kaempf, Nicola Long, Daniel Bottomly, Olga Nikolova, Brian J Druker, Shannon K McWeeney, Bill H Chang, Jeffrey W Tyner, Anupriya Agarwal
Associating drug sensitivity with differentiation status identifies effective combinations for acute myeloid leukemia. Blood advances 6 (10) (2022)
William G Rice, Stephen B Howell, Hongying Zhang, Nasrin Rastgoo, Andrea Local, Stephen E Kurtz, Pierrette Lo, Daniel Bottomly, Beth Wilmot, Shannon K McWeeney, Brian J Druker, Jeffrey W Tyner
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid Leukemia. Molecular cancer therapeutics 21 (7) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Jeffrey W Tyner, Franziska Haderk, Anbarasu Kumaraswamy, Linda B Baughn, Brian Van Ness, Song Liu, Himangi Marathe, Joshi J Alumkal, Trever G Bivona, Keith Syson Chan, Brian J Druker, Alan D Hutson, Peter S Nelson, Charles L Sawyers, Christopher D Willey
Understanding Drug Sensitivity and Tackling Resistance in Cancer. Cancer research 82 (8) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Theodore P Braun, Joseph Estabrook, Zachary Schonrock, Brittany M Curtiss, Lucie Darmusey, Jommel Macaraeg, Trevor Enright, Cody Coblentz, Rowan Callahan, William M Yashar, Akram Taherinasab, Hisham Mohammed, Daniel J Coleman, Brian J Druker, Emek Demir, Theresa A Lusardi, Julia E Maxson
Asxl1 deletion disrupts MYC and RNA polymerase II function in granulocyte progenitors. Leukemia 37 (2) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Mayra A Gonzalez, Idaly M Olivas, Alfonso E Bencomo-Alvarez, Andres J Rubio, Christian Barreto-Vargas, Jose L Lopez, Sara K Dang, Jonathan P Solecki, Emily McCall, Gonzalo Astudillo, Vanessa V Velazquez, Katherine Schenkel, Kelaiah Reffell, Mariah Perkins, Nhu Nguyen, Jehu N Apaflo, Efren Alvidrez, James E Young, Joshua J Lara, Dongqing Yan, Anna Senina, Jonathan Ahmann, Katherine E Varley, Clinton C Mason, Christopher A Eide, Brian J Druker, Md Nurunnabi, Osvaldo Padilla, Sudip Bajpeyi, Anna M Eiring
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism. Clinical and translational medicine 12 (12) (2022)
Paul Yenerall, Rahul K Kollipara, Kimberley Avila, Michael Peyton, Christopher A Eide, Daniel Bottomly, Shannon K McWeeney, Yan Liu, Kenneth D Westover, Brian J Druker, John D Minna, Ralf Kittler
Lentiviral-Driven Discovery of Cancer Drug Resistance Mutations. Cancer research 81 (18) (2021)
Fei Yang, Nicola Long, Tauangtham Anekpuritanang, Daniel Bottomly, Jonathan C Savage, Tiffany Lee, Jose M Solis-Ruiz, Uma Borate, Beth Wilmot, Cristina E Tognon, Allison M Bock, Daniel A Pollyea, Saikripa Mangala Radhakrishnan, Srinidhi Radhakrishnan, Prapti Arvind Patel, Robert H Collins, Srinivas K Tantravahi, Michael W Deininger, Guang Fan, Brian J Druker, Ujwal Shinde, Jeffrey W Tyner, Richard D Press, Shannon K McWeeney, Anupriya Agarwal
Identification and prioritization of myeloid malignancy germline variants in a large cohort of adult AML patients. Blood (2021)
Brian S White, Suleiman A Khan, Mike J Mason, Muhammad Ammad-Ud-Din, Swapnil Potdar, Disha Malani, Heikki Kuusanmäki, Brian J Druker, Caroline A Heckman, Olli Kallioniemi, Stephen E Kurtz, Kimmo Porkka, Cristina E Tognon, Jeffrey W Tyner, Tero Aittokallio, Krister Wennerberg, Justin Guinney
Bayesian multi-source regression and monocyte-associated gene expression predict BCL-2 inhibitor resistance in acute myeloid leukemia. NPJ precision oncology 5 (1) (2021)
Alfonso E Bencomo-Alvarez, Andres J Rubio, Idaly M Olivas, Mayra A Gonzalez, Rebecca Ellwood, Carme Ripoll Fiol, Christopher A Eide, Joshua J Lara, Christian Barreto-Vargas, Luis F Jave-Suarez, Georgios Nteliopoulos, Alistair G Reid, Dragana Milojkovic, Brian J Druker, Jane Apperley, Jamshid S Khorashad, Anna M Eiring
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B. Oncogene 40 (15) (2021)
Helong Zhao, Anthony D Pomicter, Anna M Eiring, Anca Franzini, Jonathan Ahmann, Jae-Yeon Hwang, Anna V Senina, Bret Helton, Siddharth M Iyer, Dongqing Yan, Jamshid S Khorashad, Matthew S Zabriskie, Anupriya Agarwal, Hannah M Redwine, Amber D Bowler, Phillip M Clair, Shannon K McWeeney, Brian J Druker, Jeffrey W Tyner, Derek L Stirewalt, Vivian G Oehler, Sooryanarayana Varambally, Kristofer C Berrett, Jeffrey M Vahrenkamp, Jason Gertz, Katherine E Varley, Jerald Radich, Michael W Deininger
MS4A3 Promotes Differentiation in Chronic Myeloid Leukemia by Enhancing Common β Chain Cytokine Receptor Endocytosis. Blood (2021)
Aaron M Tsumura, Brian J Druker, Diana Brewer, Richard D Press, Theodore P Braun
BCR-ABL+ Chronic Myeloid Leukemia Arising in a Family With Inherited ANKRD26-Related Thrombocytopenia. JCO precision oncology 5 (2021)
Amy Burd, Richard L Schilsky, Brian J Druker, Ross L Levine, Vassiliki A Papadimitrakopoulou, Roy S Herbst, Mary W Redman, Brian J Druker, David R Gandara
Challenges and approaches to implementing master/basket trials in oncology. Blood advances 3 (14) (2020)
Sunil Kumar Joshi, Jamie M Keck, Christopher A Eide, Daniel Bottomly, Elie Traer, Jeffrey W Tyner, Shannon K McWeeney, Cristina E Tognon, Brian J Druker
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia. Leukemia 34 (10) (2020)
Christopher A Eide, Stephen E Kurtz, Andy Kaempf, Nicola Long, Anupriya Agarwal, Cristina E Tognon, Motomi Mori, Brian J Druker, Bill H Chang, Alexey V Danilov, Jeffrey W Tyner
Simultaneous kinase inhibition with ibrutinib and BCL2 inhibition with venetoclax offers a therapeutic strategy for acute myeloid leukemia. Leukemia 34 (9) (2020)
Bruna Alves Fenerich, Jaqueline Cristina Fernandes, Ana Paula Nunes Rodrigues Alves, Juan Luiz Coelho-Silva, Renata Scopim-Ribeiro, Priscila Santos Scheucher, Christopher A Eide, Cristina E Tognon, Brian J Druker, Eduardo Magalhães Rego, João Agostinho Machado-Neto, Fabiola Traina
NT157 has antineoplastic effects and inhibits IRS1/2 and STAT3/5 in JAK2V617F-positive myeloproliferative neoplasm cells. Signal transduction and targeted therapy 5 (1) (2020)
Amy Burd, Ross L Levine, Amy S Ruppert, Alice S Mims, Uma Borate, Eytan M Stein, Prapti Patel, Maria R Baer, Wendy Stock, Michael W Deininger, William Blum, Gary Schiller, Rebecca Olin, Mark Litzow, James Foran, Tara L Lin, Brian Ball, Michael Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha Arellano, Alison Walker, Vu H Duong, Tibor Kovacsovics, Robert H Collins, Abigail B Shoben, Nyla A Heerema, Matthew C Foster, Jo-Anne Vergilio, Tim Brennan, Christine Vietz, Eric Severson, Molly Miller, Leonard Rosenberg, Sonja Marcus, Ashley Yocum, Timothy Chen, Mona Stefanos, Brian J Druker, John C Byrd
Precision medicine treatment in acute myeloid leukemia using prospective genomic profiling: feasibility and preliminary efficacy of the Beat AML Master Trial. Nature medicine 26 (12) (2020)
Haijiao Zhang, Beth Wilmot, Daniel Bottomly, Kim-Hien T Dao, Emily Stevens, Christopher A Eide, Vishesh Khanna, Angela Rofelty, Samantha Savage, Anna Reister Schultz, Nicola Long, Libbey White, Amy Carlos, Rachel Henson, Chenwei Lin, Robert Searles, Robert H Collins, Daniel J DeAngelo, Michael W Deininger, Tamara Dunn, Than Hein, Marlise R Luskin, Bruno C Medeiros, Stephen T Oh, Daniel A Pollyea, David P Steensma, Richard M Stone, Brian J Druker, Shannon K McWeeney, Julia E Maxson, Jason R Gotlib, Jeffrey W Tyner
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis. Blood 134 (11) (2019)
Susan Branford, Dennis Dong Hwan Kim, Jane F Apperley, Christopher A Eide, Mohamed El Missiry, S Tiong Ong, Georgios Nteliopoulos, Thomas Ernst, Charles Chuah, Carlo B Gambacorti-Passerini, Michael J Mauro, Brian J Druker, Dong-Wook Kim, Francois-Xavier Mahon, Jorge Cortes, Jerry P Radich, Andreas Hochhaus, Timothy P Hughes, null null
Laying the foundation for genomically-based risk assessment in chronic myeloid leukemia. Leukemia 33 (8) (2019)
George M Burslem, Anna Reister Schultz, Daniel P Bondeson, Christopher A Eide, Samantha L Savage Stevens, Brian J Druker, Craig M Crews
Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation. Cancer research 79 (18) (2019)
Theodore P Braun, Mariam Okhovat, Cody Coblentz, Sarah A Carratt, Amy Foley, Zachary Schonrock, Brittany M Smith, Kimberly Nevonen, Brett A Davis, Brianna Garcia, Dorian LaTocha, Benjamin R Weeder, Michal R Grzadkowski, Joey C Estabrook, Hannah G Manning, Kevin Watanabe-Smith, Sophia Jeng, Jenny L Smith, Amanda R Leonti, Rhonda E Ries, Shannon K McWeeney, Cristina Di Genua, Roy Drissen, Claus Nerlov, Soheil Meshinchi, Lucia Carbone, Brian J Druker, Julia E Maxson
Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia. Nature communications 10 (1) (2019)
Haijiao Zhang, Samantha Savage, Anna Reister Schultz, Daniel Bottomly, Libbey White, Erik Segerdell, Beth Wilmot, Shannon K McWeeney, Christopher A Eide, Tamilla Nechiporuk, Amy Carlos, Rachel Henson, Chenwei Lin, Robert Searles, Hoang Ho, Yee Ling Lam, Richard Sweat, Courtney Follit, Vinay Jain, Evan Lind, Gautam Borthakur, Guillermo Garcia-Manero, Farhad Ravandi, Hagop M Kantarjian, Jorge Cortes, Robert H Collins, Daelynn R Buelow, Sharyn D Baker, Brian J Druker, Jeffrey W Tyner
Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms. Nature communications 10 (1) (2019)
Tamilla Nechiporuk, Stephen E Kurtz, Olga Nikolova, Tingting Liu, Courtney L Jones, Angelo D'Alessandro, Rachel Culp-Hill, Amanda d'Almeida, Sunil K Joshi, Mara W Rosenberg, Cristina E Tognon, Alexey V Danilov, Brian J Druker, Bill H Chang, Shannon K McWeeney, Jeffrey W Tyner
The TP53 Apoptotic Network Is a Primary Mediator of Resistance to BCL2 Inhibition in AML Cells. Cancer discovery 9 (7) (2019)

Brian J Druker.css-eqlu8i{font-size:small;padding-left:4px;} (Brian Druker, John C Byrd)

Publication Activity (10 Years)

Top Topics

Top Venues

Brian J Druker (Brian Druker, John C Byrd)